Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentric, Post-Marketing Surveillance to Monitor the Safety and Reactogenicity of GlaxoSmithKline Biologicals Hepatitis A Vaccine Administered in Korean Population.

NCT00237991 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00237991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00237991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentric, Post-Marketing Surveillance to Monitor the Safety and Reactogenicity of GlaxoSmithKline Biologicals Hepatitis A Vaccine Administered in Korean Population.
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
June 30, 2005
Completion date
Not reported
Enrollment
600
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis a